Methoctramine reveals heterogeneity of M2 muscarinic receptors in longitudinal ileal smooth muscle membranes

https://doi.org/10.1016/0014-2999(88)90434-7Get rights and content

Abstract

Direct binding studies on longitudinal ileal and atrial muscarinic receptors revealed that most of the ileal or atrial selective antagonists identified in functional studies did not differentiate between these muscarinic receptors in direct binding studies. Methoctramine, an atrial selective muscarinic receptor antagonist in functional studies was, however, able to partially discriminate between these two receptors in our binding studies. Furthermore the binding data obtained using this compound indicated that longitudinal ileal muscarinic receptors were heterogeneous. The predominant population of ileal muscarinic receptors displayed a similar pharmacology to the cardiac type M2 muscarinic receptor. The minor population of muscarinic receptors identified in binding studies displayed a similar pharmacology to the ileal muscarinic receptor identified in functional studies and were pharmacologically similar to the exocrine gland type M2 muscarinic receptor.

References (27)

  • A. Cassinelli et al.

    Selective inhibition of cardiac M-2 muscarinic receptors by polymethylene tetraamines

  • Y.-C. Cheng et al.

    Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction

    Biochem. Pharmacol.

    (1973)
  • L.K. Choo et al.

    Failure of gallamine and pancuronium to inhibit selectively (−)-[3H]quinuclidinyl benzilate binding in guinea-pig atria

    Can. J. Physiol. Pharmacol.

    (1985)
  • Cited by (94)

    • Role of muscarinic receptors in the contraction of jejunal smooth muscle in the horse: An in vitro study

      2017, Research in Veterinary Science
      Citation Excerpt :

      By contrast, a relevant role by M1 or M2 receptor subtypes in mediating the contractions induced by exogenous ACh in horse jejunum seems to be unlikely. This latter finding might seem in contrast with previous evidence of a contribution by M2 receptors to cholinergic contraction of intestinal smooth muscle (Eglen, 2001), and with the prevalence of M2 over M3 receptors found in the small intestine of several species (Giraldo et al., 1987; Michel and Whiting, 1988; Candell et al., 1990). However, the negligible role of M2 receptors in mediating the contraction induced by exogenous ACh can be explained by the fact that this muscarinic receptor subtype, by inhibiting cAMP synthesis, opposes to the relaxation of sympathetic origin (Kume and Kotlikoff, 1991; Kotlikoff et al., 1999) but is devoid of a direct contractile action on smooth muscle cells, and therefore its effect might not be evident in isolated jejunum, in absence of adrenergic stimulation.

    View all citing articles on Scopus
    View full text